Clinical Trial Update: Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating insulin glulisine shows a beneficial effect in people with Type 1 diabetes and lipoatrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipoatrophy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Kinderkrankenhaus auf der Bult | Conditions: Type 1 Diabetes, Lipoatrophy | Phase 4 | Status: COMPLETED